Webinars

Webinars

WEBINARS

Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.

Show More

MAY 08, 2024 | 7:00 AM

Advancing cancer organoid drug screening with novel media systems

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will di...

Speaker: Dr. Colin Paul , Dr. Christophe Deben, Ph.D. Oncology and Cancer Biology

Sponsored By: Thermo Fisher Scientific

18 1
MAY 07, 2024 | 8:00 AM

C.E. CREDITS

Is It Anti-RNP or Anti-Sm/RNP?

Antibodies against ribonucleoprotein (RNP) are an important serologic marker for mixed connective tissue disease (MCTD). RNP interacts with Smith (Sm) proteins to form the Sm/RNP complex. An...

Speaker: Dr. Lisa Peterson, Ph.D., D(AMBLI)

Sponsored By: Bio-Rad Laboratories

42
MAY 3, 2024 3:30 PM ET

Certified, Sustainable and Safe Ductless Air Filtration Solutions.

Creating a lab with Ductless Air Filtration Solutions that provides certified, sustainable, safety wherever your science takes you....

Speaker: Jesse Coiro

Presented at: The Thomas Experts Series & The Thomas Center Labs
Sponsored By: Erlab, Erlab

9
APR 30, 2024 | 3:00 PM

The Promise of B-Cell Epitope Immunotherapies: Combinatorial HER-2,...

In light of the numerous US FDA-approved humanized monoclonal antibodies (mAbs) for cancer immunotherapy, it is surprising that the advancement of B-cell epitope vaccines designed to elicit...

Speaker: Pravin T.P. Kaumaya, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: Luminex

1
APR 30, 2024 | 2:00 PM

Bringing Cancer Immunotherapies to Market: Addressing Manufacturing...

Cell-based therapeutics show immense promise in treating a variety of currently incurable diseases due to their potent mechanisms. However, despite recent successes, challenges persist in ma...

Speaker: Daksha Patel, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: GenScript

2
APR 30, 2024 | 2:00 PM

Key Strategies and Points in Circular RNA Process Development...

The recognition of mRNA molecules as a transformative class of therapeutic drugs has soared, particularly with the development of COVID 19 mRNA vaccines. The cancer treatment landscape is si...

Speaker: Serena Zhao, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: Yxgene

2
APR 30, 2024 | 1:00 PM

Keynote Presentation: Modeling the Holistic Journey of Solid Tumor...

Chimeric antigen receptor (CAR) T-cell therapy shows significant potential in treating various human cancers. Unfortunately, researchers have faced difficulty in adapting this therapy to tar...

Speaker: Anita Mehta, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: Emulate

1
APR 30, 2024 | 12:00 PM

Chimeric Antigen Receptor (CAR)-associated Cellular Immunotherapy:...

Chimeric antigen receptor (CAR) T cell therapy has emerged as a novel therapeutic option for cancer patients in recent years. Despite its success, this approach faces acknowledged limitation...

Speaker: Qiongsi (Alston) Zhang, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: Sino Biological

2
APR 30, 2024 | 12:00 PM

Advancing Therapeutic Antibody Development: Cutting-Edge Technologies...

This presentation looks at the dynamic landscape of therapeutic antibody development, focusing on next-generation immuno-oncology therapeutics that target checkpoint inhibitors and incorpora...

Speaker: Amanda Grimm, B.S., PSM

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: GenScript

1
APR 30, 2024 | 10:30 AM

C.E. CREDITS

Keynote Presentation: Engineering Metabolically Fit, Memory-Rich...

Despite the remarkable clinical efficacy of chimeric antigen receptor (CAR) T cells in hematological malignancies, only a subset of patients achieve a durable complete response. Furthermore,...

Speaker: Sarwish Rafiq, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024

2
APR 30, 2024 | 9:00 AM

C.E. CREDITS

Keynote Presentation: Functional Discovery of T Cell Receptors...

Nanovials are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell seq...

Speaker: Dino Di Carlo, Ph.D.

Presented at: Immuno-Oncology Virtual Event Series 2024

2
APR 30, 2024 | 7:30 AM

C.E. CREDITS

Keynote Presentation: Targeting T-cell Malignancies with CAR-based...

Chimeric antigen receptor (CAR) T-cell therapy has been extremely successful in treating relapsed/refractory B-cell malignancies, with six CAR T-cell products now FDA approved. Unfortunately...

Speaker: Sunil S. Raikar, MD

Presented at: Immuno-Oncology Virtual Event Series 2024

3
APR 30, 2024 | 6:00 AM

Solutions for Accelerating the Maturation of Cancer Vaccines with...

In the field of tumor immunotherapy, cancer vaccines are designed to help the immune system recognize and attack cancer cells. More efforts are needed to identify neoantigens, develop combin...

Speaker: Melody Chang

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: GenScript

2
APR 30, 2024 | 6:00 AM

Panel Presentation: Advances in High Sensitivity Protein Detection...

Circulating proteins found in biofluids represent ideal biomarkers for early disease detection and can be collected non-invasively. Detection from biofluids, however, is challenging as highl...

Speaker: Xiao-Jun Ma, PhD , Yuehan Feng, PhD , Alex Forrest-Hay

Presented at: Immuno-Oncology Virtual Event Series 2024
Sponsored By: Alamar Biosciences

3
On Demand

C.E. CREDITS

Engineering T Cells to Stimulate Endogenous Antitumor Immunity

Adoptive cell therapy (ACT) is an immunotherapy that employs living immune cells to target and destroy cancer cells. However, the inhibitory tumor microenvironment features several obstacles...

Speaker: Shannon K. Oda, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024

3
On Demand

C.E. CREDITS

Targeting Tumor-Intrinsic Pathways to Enhance Immunotherapy

Throughout history, various approaches including surgery, radiation therapy, chemotherapy, and targeted therapy have been employed in the fight against cancer. In the 2010s, the emergence of...

Speaker: Jia Shen, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024

1
On Demand

The Importance of a Serum-Free, Chemically-Defined Manufacturing...

Cell-based therapies are advanced medical treatments for cancers and other diseases. Autologous and allogeneic cell therapies use immune cells from either a patient or from healthy donor sam...

Speaker: Sam Bhattacharya, PhD, MBA

Presented at: Immuno-Oncology Virtual Event Series 2024

2
On Demand

C.E. CREDITS

Immunomechanics and Mechano-Immunology in Brain Cancer

Brain cancer research stands to benefit from the perspectives, tools, and methodologies of non-traditional fields, such as mechanical engineering. Here, I will discuss our engineering-based...

Speaker: Meenal Datta, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024

2
On Demand

C.E. CREDITS

Investigating the Spatial Organization of the Immune Response...

Understanding the spatial organization of the immune response within tumors is crucial for developing effective cancer immunotherapies. In this seminar, we delve into the interactions betwee...

Speaker: Kate Carbone, PhD

Presented at: Immuno-Oncology Virtual Event Series 2024

3
APRIL 26, 2024 3:30 PM ET

The Impact of Annex 1 and Your Contamination Control Strategy

This presentation will cover the purpose of the Annex 1 update, scope, principles, regulatory expectations, what's next and solutions to help ensure readiness....

Speaker: Donald Singer

Presented at: The Thomas Experts Series & The Thomas Center Labs
Sponsored By: Ecolab, Vert Clinical Leader

6
APR 25, 2024 | 3:00 PM

C.E. CREDITS

Navigating Renal Tumor Pathology: Insights and Innovations

A comprehensive exploration of the latest advancements in the pathology of renal tumors. This one-hour webinar will explore the intricacies of renal tumor pathology, focusing on recent devel...

Speaker: Francisco G. La Rosa, MD, FCAP

Presented at: Precision Medicine in Solid Tumors

4
APR 24, 2024 | 8:00 AM

C.E. CREDITS

LESSONS FROM THE LABORATORY: OPTIMIZING YOUR TISSUE PROCESSING

Has your research results or laboratory processes been bogged down by poor staining quality of histology slides? We all know that proper tissue processing is a key element to downstream stai...

Speaker: Robin Fitzl, BS, HT(ASCP)

Sponsored By: Leica Biosystems

29
APR 24, 2024 | 6:00 AM

Unlocking disease risk insights: explore the UK Biobank data enhanced...

Over the past few decades, protein analysis and proteomics have emerged as crucial tools in disease risk assessment, providing a more holistic understanding of susceptibility to diseases and...

Speaker: Kristin Hellman, MSc , Ola Caster, PhD

Sponsored By: Olink Proteomics

19 1
APR 23, 2024 | 7:00 AM

Roundtable: Demystifying preimplantation genetic testing for monogenic...

Preimplantation genetic testing (PGT) has become commonplace in research during in vitro fertilisation (IVF) procedures. Various PGT methods are utilised to assess blastocysts suitability fo...

Speaker: Dr. Ana Bustamante Aragonés , Dr. Federica Cariati, MSc, PhD

Sponsored By: Thermo Fisher Scientific

15
APR 22, 2024 | 9:00 AM

Enabling cell culture researchers to advance sustainability in...

Maintaining healthy cells is the key to experimental success and reproducible research results. To give you confidence in your cell cultures, the Gibco, Thermo Scientific Nunc, and Invitroge...

Speaker: Sune Lund Sporring, MSc, PhD

Sponsored By: Thermo Fisher Scientific

24
APR 19, 2024 | 12:00 AM

C.E. CREDITS

Direct Oral Anticoagulants (DOACs): Measurands and Interferents...

Explore DOACs' impact on coagulation testing, lab methods to detect interference, and approaches for urgent patient care decisions...

Speaker: Anna Merrill, PhD, DABCC

Presented at: Stago EdVantage Virtual University
Sponsored By: Diagnostica Stago, Inc.

14
APR 18, 2024 | 8:00 AM

Miniaturize to maximize your laboratory efficiency

This webinar will demonstrate how the MANTIS and TEMPEST liquid dispensers enable assay automation and miniaturization in various applications such as PCR, NGS, immunoassays, and cell and or...

Speaker: Dr. Usman Ashraf

Sponsored By: Formulatrix

18